Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: S&L dotOB

Dec 11, 2006 05:07PM

Dec 11, 2006 06:15PM

Dec 12, 2006 10:25AM

Dec 12, 2006 11:22AM

Dec 12, 2006 04:12PM

Dec 12, 2006 04:24PM

Dec 12, 2006 04:40PM

Dec 13, 2006 02:57AM

Dec 13, 2006 05:45AM

Ease,

"You believe that S&L would have to file with the SEC if they were to go over 4.99%, or 9.99 % combined, but per their agreement with PTSC, that won't happen, so they will never go over the prescribe amount. That pt should be obvious."

Currently S&L are over 5% combined and that is the reporting threshold...aquiring a >5% stake whether it be one person or beneficial, S&L, percipitates a SEC filing. S&L are beneficially over the 5% mark and thats why they had to file the 13G. You say that wont ever happen but it did and thats why they had to file.

http://www.gsionline.com/support/for...

This Schedule discloses beneficial ownership of certain registered equity securities. Any person or group of persons who acquire a beneficial ownership of more than 5% of a class of registered equity securities of certain issuers must file a Schedule 13D reporting such acquisition together with certain other information within ten days after such acquisition. Moreover, any material changes in the facts set forth in the Schedule generally precipitates a duty to promptly file an amendment on Schedule 13D. The Commission's rules define the term "beneficial owner" to be any person who directly or indirectly shares voting power or investment power (the power to sell the security).


Dec 13, 2006 07:38AM

Dec 13, 2006 07:40AM

Dec 13, 2006 07:47AM

Dec 13, 2006 07:55AM
Share
New Message
Please login to post a reply